THE REASONS ACUTE STROKE PATIENTS NOT RECEIVING THROMBOLYSIS IN AN INDONESIAN REFERRAL HOSPITAL
Journal Title: International Journal of Pharmacy and Pharmaceutical Sciences - Year 2019, Vol 11, Issue 11
Abstract
Objective: The aim of this study was to identify reasons acute stroke patients did not receive thrombolysis despite meeting Code Stroke activation criteria in Cipto Mangunkusumo General Hospital during November 2015 until February 2019. Methods: This study retrospectively collected data of adult (aged>18 y old) acute stroke patients admitted to Cipto Mangunkusumo General Hospital from November 2015 to February 2019 who met criteria for Code Stroke activation but did not undergo thrombolysis. Patient’ data were collected from Code Stroke Registry of Cipto Mangunkusumo General Hospital. Results: There were 518 acute stroke patients who had Code Stroke activated in Cipto Mangunkusumo General Hospital from November 2015 to February 2019. 76.3% of acute stroke patients did not receive thrombolytic therapy (n=395). Hemorrhage on computed tomography (CT) scan was the most common reason patients did not receive thrombolysis. The following most common reasons were low or improved National Institutes of Health Stroke Scale (NIHSS) score, family refusal, and exceedance of time window. Conclusion: Hemorrhage on CT scan was the most common reason patients did not receive thrombolysis following by low or improved NIHSS score, family refusal, and exceedance of time window.
Authors and Affiliations
AL RASYID, SALIM HARRIS, MOHAMMAD KURNIAWAN, TAUFIK MESIANO, RAKHMAD HIDAYAT, Beny Rilianto, RATU AZIZAH SHOLEHA
Keywords
Related Articles
- EP ID EP667935
- DOI 10.22159/ijpps.2019v11i11.35373
- Views 101
- Downloads 0
TOXICOLOGICAL AND PHARMACOLOGICAL ASSESSMENT OF GOLD NANORODS IN NORMAL RATS
Objective: assessment of acute, subchronic and chronic toxicity of pegylated gold nanorods (PEG-gold NRs) in Wistar rats of both sex in three routes of administration {intravenous (IV), intramuscular (IM) and subcutaneou...
A CASE REPORT: DRUG INTERACTION BETWEEN LINEZOLID AND DOPAMINE
Linezolid is a weak, non-selective inhibitor of monoamine oxidase (MAO). It can inhibit the breakdown of the tyramine by MAO in the gut and can also potentiate the effect of tyramine at nerve endings, thereby causing an...
OCULAR TOLERANCE AND IN-VITRO RELEASE OF CHLORAMPHENICOL IN PROSPECTIVE EYE OINTMENT BASES
Objective: Chloramphenicol is poorly released from official eye ointment (EO) base. This study investigated alternative promising bases, enhanced drug release with surfactant and evaluated ocular tolerance of prototypes....
DEVELOPMENT OF AN INDICATOR BASED TOOL FOR THE ASSESSMENT OF MEDICINES SELECTION PRACTICES IN VARIOUS PUBLIC SECTOR HOSPITALS
Objective: To develop and validate an indicator based assessment tool for carrying out an in-depth assessment of drug selection practices prevalent at various public health facilities.Methods: The study was designed acro...
OPTIMIZATION OF CULTURE PARAMETERS FOR α-GLUCOSIDASE PRODUCTION FROM PROTONEMAL BIOMASS OF BRYUM CORONATUM SCHWAEGR
Objective: The purpose of the present investigation was to optimization of culture parameters for α-glucosidase production from protonemal biomass of Bryum coronatum Schwaegr.Methods: Fresh unopened, mature capsules wer...